Page 1340 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Chapter 96
https://kat.cr/user/tahir99/

REFERENCES

1. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxy- 16. Gladwin MT, Vichinsky E. Pulmonary complications of sickle
urea on the frequency of painful crises in sickle cell anemia. cell disease. N Engl J Med. 2008;359(21):2254-2265.
Investigators of the Multicenter Study of Hydroxyurea in Sickle 17. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and
Cell Anemia. N Engl J Med. 1995;332:1317. outcomes of the acute chest syndrome in sickle cell disease.
2. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea National Acute Chest Syndrome Study Group. N Engl J Med.
on mortality and morbidity in adult sickle cell anemia: risks and 2000;342:1855.
benefits up to 9 years of treatment. JAMA. 2003;289:1645. 18. Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism:
3. Reiter CD, Gladwin MT. An emerging role for nitric oxide in a distinct cause of severe acute chest syndrome in sickle cell
sickle cell disease vascular homeostasis and therapy. Curr Opin anemia. Blood. 1994;83:3107.
Hematol. 2003;10:99. 19. Styles LA, Schalkwijk CG, Aarsman AJ, et al. Phospholipase
4. Frenette PS. Sickle cell vaso-occlusion: multistep and multicel- A2 levels in acute chest syndrome of sickle cell disease. Blood.
lular paradigm. Curr Opin Hematol. 2002;9:101. 1996;87:2573.
5. Stuart MJ, Setty BN. Hemostatic alterations in sickle cell disease: 20. Stuart MJ, Setty BN. Acute chest syndrome of sickle cell disease:
relationships to disease pathophysiology. Pediatr Pathol Mol new light on an old problem. Curr Opin Hematol. 2001;8:111.
Med. 2001;20:27. 21. Morris CR, Vichinsky EP, Van Warmerdam J, et al. Hydroxyurea
6. Steinberg MH, Brugnara C. Pathophysiological-based approaches and arginine therapy: impact on nitric oxide production in
to treatment of sickle cell disease. Annu Rev Med. 2003;54:89. sickle cell disease. J Pediatr Hematol Oncol. 2003;25:629.
7. Aidoo M, Terlouw DJ, Kolczak MS, et al. Protective effects of the 22. Gladwin MT, Rodgers GP. Pathogenesis and treatment of acute
sickle cell gene against malaria morbidity and mortality. Lancet. chest syndrome of sickle-cell anaemia. Lancet. 2000;355:1476.
2002;359:1311. 23. Dessap AM, Deux JF, Abidi N, et al. Pulmonary artery throm-
8. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglo- bosis during acute chest syndrome in sickle cell disease. Am J
bin limits nitric oxide bioavailability in sickle-cell disease. Nat Respir Crit Care Med. 2011;184(9):1022-1029.
Med. 2002;8:1383. 24. Gladwin MT, Kato GJ, Weiner D, et al. Nitric oxide for inhala-
9. Aslan M, Ryan TM, Adler B, et al. Oxygen radical inhibition of tion in the acute treatment of sickle cell pain crisis: a random-
nitric oxide-dependent vascular function in sickle cell disease. ized controlled trial. JAMA. 2011;305(9):893-902.
Proc Natl Acad Sci USA. 2001;98:15215. 25. Ortiz FO, Aldrich TK, Nagel RL, et al. Accuracy of pulse
10. Gladwin MT, Schechter AN, Ognibene FP, et al. Divergent nitric oximetry in sickle cell disease. Am J Respir Crit Care Med.
oxide bioavailability in men and women with sickle cell disease. 1999;159:447.
Circulation. 2003;107:271. 26. Fitzgerald RK, Johnson A. Pulse oximetry in sickle cell anemia.
11. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogen- Crit Care Med. 2001;29:1803.
esis and rationale for treatment. Blood. 1999;94:1555. 27. Blaisdell CJ, Goodman S, Clark K, et al. Pulse oximetry is a
12. Loscalzo J. Nitric oxide insufficiency, platelet activation, and poor predictor of hypoxemia in stable children with sickle cell
arterial thrombosis. Circ Res. 2001;88:756. disease. Arch Pediatr Adolesc Med. 2000;154:900.
13. Jison ML, Gladwin MT. Hemolytic anemia-associated pulmo- 28. Emre U, Miller ST, Rao SP, et al. Alveolar-arterial oxygen
nary hypertension of sickle cell disease and the nitric oxide/ gradient in acute chest syndrome of sickle cell disease. J Pediatr.
arginine pathway. Am J Respir Crit Care Med. 2003;168:3. 1993;123:272.
14. Cohen SB, Fletcher ME, Goldberg MF, et al. Diagnosis and 29. Vichinsky EP. Current issues with blood transfusions in sickle
management of ocular complications of sickle hemoglobinopa- cell disease. Semin Hematol. 2001;38:14.
thies: Part V. Ophthalmic Surg. 1986;17:369. 30. Bernini JC, Rogers ZR, Sandler ES, et al. Beneficial effect of
15. Castro O, Hoque M, Brown BD. Pulmonary hypertension in intravenous dexamethasone in children with mild to mod-
sickle cell disease: cardiac catheterization results and survival. erately severe acute chest syndrome complicating sickle cell
Blood. 2003;101:1257. disease. Blood. 1998;92:3082.

Section07-O-ref.indd 1 1/21/2015 11:26:52 AM